{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T12:41:00Z","timestamp":1768221660331,"version":"3.49.0"},"reference-count":64,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background\/Objectives: Recently, the Herpes Zoster (HZ) vaccination has been introduced, alongside influenza and pneumococcal vaccination, at age 65. Factors influencing adherence to this vaccination and its clinical benefits are not completely understood. The aim of this study was to evaluate factors influencing adherence to HZ vaccination compared to pneumococcal and influenza and to assess its clinical effect in preventing acute vascular events. Methods: A total of 1152 patients (520 males), having a birth cohort from 1952 to 1959 inclusive, was recruited, belonging to the District of Udine (N = 839) and to the ASAPs 2 and 3 of Pordenone (N = 313). For each patient, a form was compiled. Results: HZ vaccination was administered to 498 patients, influenza to 665, and pneumococcal to 742 (p &lt; 0.0001). Among the vaccinated, 266 received the live-attenuated version, and 232 the recombinant HZ vaccine. In logistic regression, the presence of addictions, low educational level, and poor socioeconomic status were strongly associated with lower vaccine adherence. The presence of chronic diseases enhanced only pneumococcal (p &lt; 0.001) and influenza (p &lt; 0.001) vaccine adherence. Forty-two non-fatal acute vascular events were recorded from age 65 onwards: 14 cardiac, 20 cerebrovascular, and 8 peripheric. Only 6\/493 patients experienced an event following HZ vaccination compared to 36\/659 unvaccinated subjects (p = 0.0003). In Cox modeling, HZ vaccination proved to be an independent predictor in preventing subsequent acute vascular events (p &lt; 0.001). Conclusions: The presence of pathologies does not enhance adherence to HZ vaccination while an unfavorable socio-environmental context greatly hinders it. HZ vaccination, but not influenza and pneumococcal vaccination, appears to protect against the occurrence of acute vascular events.<\/jats:p>","DOI":"10.3390\/vaccines14010079","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T09:13:01Z","timestamp":1768209181000},"page":"79","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond the Virological Benefits of the Herpes Zoster Vaccine in the Context of Primary Care"],"prefix":"10.3390","volume":"14","author":[{"given":"Carlo","family":"Fabris","sequence":"first","affiliation":[{"name":"Hepatology and Liver Transplantation Unit, Azienda Sanitaria Universitaria Integrata, University of Udine, Faculty of Medicine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"De Cecco Beolchi","sequence":"additional","affiliation":[{"name":"Center of Formation in General Medicine (CEFORMED), 34074 Monfalcone, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Casatta","sequence":"additional","affiliation":[{"name":"Health District of Udine, Azienda Sanitaria Universitaria Integrata Friuli Centrale, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3203-1664","authenticated-orcid":false,"given":"Stefano","family":"Celotto","sequence":"additional","affiliation":[{"name":"Health District of Udine, Azienda Sanitaria Universitaria Integrata Friuli Centrale, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Pellegrini","sequence":"additional","affiliation":[{"name":"Health District of Udine, Azienda Sanitaria Universitaria Integrata Friuli Centrale, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serafina","family":"Lovascio","sequence":"additional","affiliation":[{"name":"Health District of Udine, Azienda Sanitaria Universitaria Integrata Friuli Centrale, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Urli","sequence":"additional","affiliation":[{"name":"Health District of Udine, Azienda Sanitaria Universitaria Integrata Friuli Centrale, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2566-3041","authenticated-orcid":false,"given":"Pierluigi","family":"Toniutto","sequence":"additional","affiliation":[{"name":"Hepatology and Liver Transplantation Unit, Azienda Sanitaria Universitaria Integrata, University of Udine, Faculty of Medicine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Hill, E.M., Petrou, S., Forster, H., de Lusignan, S., Yonova, I., and Keeling, M.J. (2020). Optimising age coverage of seasonal influenza vaccination in England: A mathematical and health economic evaluation. PLoS Comput. Biol., 16.","DOI":"10.1101\/2020.03.21.20040568"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"100826","DOI":"10.1016\/j.epidem.2025.100826","article-title":"Optimizing influenza vaccine allocation by age using cost-effectiveness analysis: A comparison of 6720 vaccination program scenarios in children and adults in Belgium","volume":"51","author":"Manansala","year":"2025","journal-title":"Epidemics"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Boccalini, S., de Waure, C., Martorella, L., Orlando, P., Bonanni, P., and Bechini, A. (2025). The Evolution of Annual Immunization Recommendations Against Influenza in Italy: The Path to Precision Vaccination. Vaccines, 13.","DOI":"10.3390\/vaccines13040356"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jns.2015.10.004","article-title":"Zeroing in on zoster: A tale of many disorders produced by one virus","volume":"358","author":"Galetta","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Patil, A., Goldust, M., and Wollina, U. (2022). Herpes zoster: A Review of Clinical Manifestations and Management. Viruses, 14.","DOI":"10.3390\/v14020192"},{"key":"ref_6","first-page":"95","article-title":"Varicella-zoster virus infection: Natural history, clinical manifestations, immunity and current and future vaccination strategies","volume":"41","author":"Freer","year":"2018","journal-title":"New Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.013","article-title":"Risk of Stroke\/Transient Ischemic Attack or Myocardial Infarction with Herpes Zoster: A Systematic Review and Meta-Analysis","volume":"26","author":"Zhang","year":"2017","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/WNL.0b013e31827b1ab9","article-title":"Varicella-zoster virus vasculopathy: Immune characteristics of virus-infected arteries","volume":"80","author":"Nagel","year":"2013","journal-title":"Neurology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/infdis\/jiy385","article-title":"Herpes Zoster: Epidemiological Links with Stroke and Myocardial Infarction","volume":"218","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"106891","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106891","article-title":"Risk of, and risk factors for, vasculopathy associated with acute herpes zoster","volume":"32","author":"Yawn","year":"2023","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e027451","DOI":"10.1161\/JAHA.122.027451","article-title":"Herpes Zoster and Long-Term Risk of Cardiovascular Disease","volume":"11","author":"Curhan","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e1335","DOI":"10.1093\/cid\/ciac549","article-title":"Increased Stroke Risk Following Herpes Zoster Infection and Protection with Zoster Vaccine","volume":"76","author":"Parameswaran","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/infdis\/jiac405","article-title":"Zoster-Associated Prothrombotic Plasma Exosomes and Increased Stroke Risk","volume":"227","author":"Bubak","year":"2023","journal-title":"J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/MS9.0000000000000220","article-title":"Novel discovery of exosomes biomarker from herpes zoster viral infection: Linking to cerebrovascular coincidence","volume":"85","author":"Amin","year":"2023","journal-title":"Ann. Med. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(09)70134-6","article-title":"Varicella zoster virus vasculopathies: Diverse clinical manifestations, laboratory features, pathogenesis, and treatment","volume":"8","author":"Gilden","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Marra, F., Ruckenstein, J., and Richardson, K. (2017). A meta-analysis of stroke risk following herpes zoster infection. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2278-z"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"61mr1","DOI":"10.1126\/scitranslmed.3001738","article-title":"A crisis of public confidence in vaccines","volume":"2","author":"Black","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4161\/hv.24657","article-title":"Vaccine hesitancy: An overview","volume":"9","author":"Dube","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1016\/j.vaccine.2011.06.115","article-title":"Validity and reliability of a survey to identify vaccine-hesitant parents","volume":"29","author":"Opel","year":"2011","journal-title":"Vaccine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: Definition, scope and determinants","volume":"33","author":"MacDonald","year":"2015","journal-title":"Vaccine"},{"key":"ref_21","first-page":"1","article-title":"Childhood vaccine coverage in Italy after the new law on mandatory immunization","volume":"30","author":"Signorelli","year":"2018","journal-title":"Ann. Ig."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Janssens, A., Vaes, B., Abels, C., Crevecoeur, J., Mamouris, P., Merckx, B., Libin, P., Van Pottelbergh, G., and Neyens, T. (2023). Pneumococcal vaccination coverage and adherence to recommended dosing schedules in adults: A repeated cross-sectional study of the INTEGO morbidity registry. BMC Public Health, 23.","DOI":"10.1186\/s12889-023-15939-7"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12931-021-01639-6","article-title":"Does pulmonary subspecialty referral from primary care affect the adherence to vaccination recommendations in COPD patients?","volume":"22","author":"Crothers","year":"2021","journal-title":"Respir. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.17269\/s41997-024-00893-7","article-title":"Socioeconomic, health-related, and primary care physician characteristics associated with adherence to seasonal influenza vaccination in Manitoba, Canada: A population-wide record-linkage cohort study","volume":"115","author":"Okoli","year":"2024","journal-title":"Can. J. Public Health"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.7326\/M23-2023","article-title":"Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting","volume":"177","author":"Zerbo","year":"2024","journal-title":"Ann. Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2176065","DOI":"10.1080\/21645515.2023.2176065","article-title":"Public health impact of herpes zoster vaccination on older adults in Hong Kong","volume":"19","author":"Chan","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00592-023-02127-7","article-title":"Efficacy and effectiveness of Herpes zoster vaccination in adults with diabetes mellitus: A systematic review and meta-analysis of clinical trials and observational studies","volume":"60","author":"Silverii","year":"2023","journal-title":"Acta Diabetol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.23736\/S0026-4806.19.06412-7","article-title":"Herpes zoster: Vaccination status and virtuous experiences","volume":"111","author":"Cocchio","year":"2020","journal-title":"Minerva Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4161\/hv.34363","article-title":"Reducing the burden of Herpes Zoster in Italy","volume":"11","author":"Gabutti","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_30","first-page":"23","article-title":"Herpes zoster vaccine: A protection for the elderly","volume":"30","author":"Facciola","year":"2018","journal-title":"Ann. Ig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000504484","article-title":"Herpes Zoster and Its Prevention by Vaccination","volume":"43","author":"Johnson","year":"2020","journal-title":"Interdiscip. Top. Gerontol. Geriatr."},{"key":"ref_32","first-page":"CD008858","article-title":"Vaccines for preventing herpes zoster in older adults","volume":"10","author":"Gagliardi","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3949\/ccjm.84a.16020","article-title":"Preventing herpes zoster through vaccination: New developments","volume":"84","author":"Le","year":"2017","journal-title":"Cleve Clin. J. Med."},{"key":"ref_34","first-page":"135","article-title":"New challenges in vaccination policies: The role of General Practitioners","volume":"91","author":"Signorelli","year":"2020","journal-title":"Acta Biomed."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S1386-6532(10)70005-6","article-title":"Management of herpes zoster and post-herpetic neuralgia now and in the future","volume":"48","author":"Whitley","year":"2010","journal-title":"J. Clin. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","article-title":"Population-based study of herpes zoster and its sequelae","volume":"61","author":"Ragozzino","year":"1982","journal-title":"Medicine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000024949","article-title":"Demography, symptomatology, and course of disease in ambulatory zoster patients. A physician-based survey in Germany","volume":"41","author":"Meister","year":"1998","journal-title":"Intervirology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5694\/j.1326-5377.2008.tb01566.x","article-title":"The prevention and management of herpes zoster","volume":"188","author":"Cunningham","year":"2008","journal-title":"Med. J. Aust."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1038\/s41598-023-29667-w","article-title":"Herpes zoster and long-term vascular risk: A retrospective cohort study","volume":"13","author":"Horev","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1212\/WNL.0000000000000584","article-title":"Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK","volume":"83","author":"Breuer","year":"2014","journal-title":"Neurology"},{"key":"ref_41","first-page":"e61419","article-title":"Varicella Zoster Virus Vasculopathy: An Under-Recognized Entity","volume":"16","author":"Philip","year":"2024","journal-title":"Cureus"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2017.03.014","article-title":"Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesis","volume":"308","author":"Nagel","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Wu, P.H., Chuang, Y.S., and Lin, Y.T. (2019). Does Herpes Zoster Increase the Risk of Stroke and Myocardial Infarction? A Comprehensive Review. J. Clin. Med., 8.","DOI":"10.3390\/jcm8040547"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.puhe.2024.01.024","article-title":"Time-varying association between herpes zoster infection and subsequent occurrence of stroke","volume":"229","author":"Lapi","year":"2024","journal-title":"Public Health"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Erskine, N., Tran, H., Levin, L., Ulbricht, C., Fingeroth, J., Kiefe, C., Goldberg, R.J., and Singh, S. (2017). A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181565"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Minassian, C., Thomas, S.L., Smeeth, L., Douglas, I., Brauer, R., and Langan, S.M. (2015). Acute Cardiovascular Events after Herpes Zoster: A Self-Controlled Case Series Analysis in Vaccinated and Unvaccinated Older Residents of the United States. PLoS Med., 12.","DOI":"10.1371\/journal.pmed.1001919"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Yamaoka-Tojo, M., and Tojo, T. (2024). Herpes Zoster and Cardiovascular Disease: Exploring Associations and Preventive Measures through Vaccination. Vaccines, 12.","DOI":"10.3390\/vaccines12030252"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/infdis\/jiaf105","article-title":"Protective Effects of Recombinant Zoster Vaccine and Antiviral Therapy Against Cardiovascular Disease Following Herpes Zoster Infection","volume":"232","author":"Xu","year":"2025","journal-title":"J. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e708","DOI":"10.1212\/WNL.0000000000010028","article-title":"Effect of herpes zoster vaccine and antiviral treatment on risk of ischemic stroke","volume":"95","author":"Yang","year":"2020","journal-title":"Neurology"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Jia, Y.H., Dong, Y.B., Jiang, H.Y., and Li, A.J. (2023). Effects of herpes zoster vaccination and antiviral treatment on the risk of stroke: A systematic review and meta-analysis. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1176920"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/STROKEAHA.120.032788","article-title":"Herpes Zoster Vaccine Live and Risk of Stroke Among Medicare Beneficiaries: A Population-Based Cohort Study","volume":"52","author":"Yang","year":"2021","journal-title":"Stroke"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1093\/eurheartj\/ehaf230","article-title":"Live zoster vaccination and cardiovascular outcomes: A nationwide, South Korean study","volume":"46","author":"Lee","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_53","first-page":"e12293","article-title":"Reduced dementia incidence after varicella zoster vaccination in Wales 2013\u20132020","volume":"8","author":"Schnier","year":"2022","journal-title":"Alzheimers Dement"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Lophatananon, A., Carr, M., McMillan, B., Dobson, C., Itzhaki, R., Parisi, R., Ashcroft, D.M., and Muir, K.R. (2023). The association of herpes zoster and influenza vaccinations with the risk of developing dementia: A population-based cohort study within the UK Clinical Practice Research Datalink. BMC Public Health, 23.","DOI":"10.1186\/s12889-023-16768-4"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2546741","DOI":"10.1080\/21645515.2025.2546741","article-title":"Effects of herpes zoster infection, antivirals and vaccination on risk of developing dementia: A systematic review and meta-analysis","volume":"21","author":"Marra","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-025-08800-x","article-title":"A natural experiment on the effect of herpes zoster vaccination on dementia","volume":"641","author":"Eyting","year":"2025","journal-title":"Nature"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1038\/s41591-024-03201-5","article-title":"The recombinant shingles vaccine is associated with lower risk of dementia","volume":"30","author":"Taquet","year":"2024","journal-title":"Nat. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"126673","DOI":"10.1016\/j.vaccine.2024.126673","article-title":"Recombinant zoster vaccine and the risk of dementia","volume":"46","author":"Tang","year":"2025","journal-title":"Vaccine"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.2025.5013","article-title":"Herpes Zoster Vaccination and Dementia Occurrence","volume":"333","author":"Pomirchy","year":"2025","journal-title":"JAMA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/BOR.0000000000000292","article-title":"Varicella zoster virus triggers the immunopathology of giant cell arteritis","volume":"28","author":"Gilden","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1080\/14760584.2025.2514527","article-title":"Breaking the cycle: Considerations for a life-course vaccination strategy against varicella-zoster virus","volume":"24","author":"Casabona","year":"2025","journal-title":"Expert Rev. Vaccines"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Bakker, K.M., Eisenberg, M.C., Woods, R.J., and Martinez, M.E. (2022). Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation. BMC Med., 20.","DOI":"10.1186\/s12916-022-02534-7"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1038\/s41591-025-03972-5","article-title":"Varicella-zoster virus reactivation and the risk of dementia","volume":"31","author":"Polisky","year":"2025","journal-title":"Nat. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(05)67702-1","article-title":"Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)","volume":"366","author":"Rothwell","year":"2005","journal-title":"Lancet"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/1\/79\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T09:34:56Z","timestamp":1768210496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/1\/79"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,11]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["vaccines14010079"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14010079","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,11]]}}}